Biora Therapeutics Inc expected to post a loss of $1.44 a share - Earnings Preview

Biora Therapeutics

28/03/2023 21:23

* Biora Therapeutics Inc  BIOR.OQ   BIOR.O  is expected
to show a
fall in quarterly revenue when it reports  results on March 30. 
    * The San Diego California-based  company is expected to
report  a
87.4% decrease in revenue to $55 thousand from $435 thousand a
year ago, according to the mean estimate from 2 analysts, based
on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Biora Therapeutics
Inc is
for a loss of $1.44 per share. 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 2 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Biora
Therapeutics Inc is $82.5​, above​ its last closing price
of $2.67. ​​​

This summary was machine generated March 28 at 20:23 GMT.  All
figures in US dollars  unless otherwise stated